Robustness of RNA sequencing on older formalin-fixed paraffin-embedded tissue from high-grade ovarian serous adenocarcinomas.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2019
2019
Historique:
received:
16
10
2018
accepted:
12
04
2019
entrez:
7
5
2019
pubmed:
7
5
2019
medline:
14
1
2020
Statut:
epublish
Résumé
Formalin-fixed paraffin-embedded (FFPE) tissues are among the most widely available clinical specimens. Their potential utility as a source of RNA for transcriptome studies would greatly enhance population-based cancer studies. Although preliminary studies suggest FFPE tissue may be used for RNA sequencing, the effect of storage time on these specimens needs to be determined. We conducted this study to determine whether RNA in archived FFPE high-grade ovarian serous adenocarcinomas from Surveillance, Epidemiology and End Results (SEER) registries was present in sufficient quantity and quality for RNA-Seq analysis. FFPE tissues, stored from 7 to 32 years, were obtained from three SEER sites. RNA was extracted, quantified, quality assessed, and subjected to RNA-Seq (a whole transcriptome sequencing technology). FFPE specimens stored for longer periods of time had poorer RNA sample quality as indicated by negative correlations between specimen storage time and fragment distribution values (DV). In addition, sample contamination was a common issue among the RNA, with 41 of 67 samples having 5% to 48% bacterial contamination. However, regardless of specimen storage time and bacterial contamination, 60% of the samples yielded data that enabled gene expression quantification, identifying more than 10,000 genes, with the correlations among most biological replicates above 0.7. This study demonstrates that FFPE high-grade ovarian serous adenocarcinomas specimens stored in repositories for up to 32 years and under varying storage conditions are a promising source of RNA for RNA-Seq. We also describe certain caveats to be considered when designing RNA-Seq studies using archived FFPE tissues.
Identifiants
pubmed: 31059554
doi: 10.1371/journal.pone.0216050
pii: PONE-D-18-29989
pmc: PMC6502345
doi:
Substances chimiques
RNA, Neoplasm
0
Formaldehyde
1HG84L3525
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0216050Déclaration de conflit d'intérêts
The Leidos Biomedical Research, Inc affiliation does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.
Références
BMC Genomics. 2014 Dec 11;15:1087
pubmed: 25495041
Toxicol Sci. 2016 Dec;154(2):202-213
pubmed: 27562560
Cancer Cell. 2010 Jan 19;17(1):98-110
pubmed: 20129251
Nature. 2011 Jun 29;474(7353):609-15
pubmed: 21720365
PLoS One. 2014 May 30;9(5):e98187
pubmed: 24878701
PLoS One. 2015 Jul 29;10(7):e0127353
pubmed: 26222067
Cell. 2013 Oct 10;155(2):462-77
pubmed: 24120142
Bioinformatics. 2016 Oct 1;32(19):3047-8
pubmed: 27312411
Genome Res. 2015 Sep;25(9):1372-81
pubmed: 26253700
BMC Genomics. 2014 Jun 02;15:419
pubmed: 24888378
Cancer Epidemiol Biomarkers Prev. 2014 Dec;23(12):2681-7
pubmed: 25472677
Int J Genomics. 2017;2017:1926304
pubmed: 28246590
Int J Genomics. 2016;2016:9837310
pubmed: 27774452
PLoS One. 2017 Jan 25;12(1):e0170632
pubmed: 28122052
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Clin Proteomics. 2018 Aug 3;15:26
pubmed: 30087585
BMC Pulm Med. 2017 Jan 12;17(1):15
pubmed: 28081703
BMC Biol. 2018 May 14;16(1):52
pubmed: 29759067
Cancer Res. 2009 Dec 1;69(23):9065-72
pubmed: 19920198
BJU Int. 2010 Jan;105(2):274-8
pubmed: 19519763
BMC Genomics. 2017 Jun 5;18(1):442
pubmed: 28583074
PLoS One. 2016 Feb 22;11(2):e0149743
pubmed: 26901863
PLoS One. 2013 Nov 22;8(11):e81925
pubmed: 24278466
Sci Rep. 2015 Jul 23;5:12335
pubmed: 26202458